Observed Signal · Oct 7, 2026 · Event · Source: EU-Startups (European Venture) · Impact: 1/5 · Sentiment: Positive
Neuroelectrics CEO Ana Maiques to keynote EU-Startups Summit 2027
Ana Maiques, co-founder and CEO of Barcelona-based neurotechnology company Neuroelectrics, will deliver a keynote at the EU-Startups Summit 2027 in Malta. The summit, scheduled for May 13-14, 2027, is expected to draw around 2,500 attendees. Maiques will share insights on scaling a deep-tech venture from research to global markets, drawing on Neuroelectrics' journey since its 2011 founding. The company raised a €15 million Series A led by Morningside Ventures in 2021 and has expanded its non-invasive brain stimulation technologies to over 74 countries. Maiques is also a co-founder of Starlab and EsTech and serves on the European Innovation Council Advisory Board, advocating for women in STEM.
The article announces a keynote speaker for an upcoming startup conference, which is relevant to the European startup ecosystem but has limited direct impact on the AdTech/MarTech industry.
Track Morningside Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Ana Maiques, co-founder and CEO of Neuroelectrics, will speak at the EU-Startups Summit 2027, taking place May 13-14 in Malta.
- Neuroelectrics raised a €15 million Series A in 2021, led by Morningside Ventures.
- The company's technologies are present in more than 74 countries.
- Neuroelectrics received around €4.49 million in EU funding for its NeuroTwin initiative.
- The summit expects around 2,500 attendees.
Connected Companies & Entities
1 Entity mapped“They raised a 15 million euro Series A in 2021, led by Morningside Ventures.”
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Marco Marlia, MotorK President, to speak at EU-Startups Summit 2027
Marco Marlia, co-founder and President of MotorK, a European SaaS provider for the automotive retail industry, will deliver a keynote at the EU-Startups Summit 2027 in Malta on May 13-14, 2027. His keynote, titled "Weathering the Storm: The right founder mindset and actions for difficult times," will draw on his experience building MotorK through growth, international expansion, fundraising, and public markets. Marlia co-founded MotorK in 2010, and the company listed on Euronext Amsterdam in 2021, raising €75 million. The company now employs over 300 people and operates in 8 countries. The summit is expected to attract around 2,500 attendees.
Circus CEO Nikolas Bullwinkel to Keynote EU-Startups Summit 2027
Nikolas Bullwinkel, founder and CEO of Munich-based robotics company Circus Group, will deliver a keynote at the EU-Startups Summit 2027 in Malta on May 13-14, focusing on AI robotics and scaling DeepTech from lab to market. Bullwinkel, who previously co-founded quick-commerce startup Flink, founded Circus in 2021 to develop AI-powered robotic systems for autonomous food production. The company raised €11 million in 2022, acquired culinary robotics startup Aitme in 2023, and went public on the Frankfurt Stock Exchange in 2024. Circus is now focused on its CA-1 autonomous food-production robot for civilian and defence applications. The event expects around 2,500 attendees.
MintNeuro raises $5M for neural device chips
MintNeuro, an Imperial College London spinout, has raised $5 million in a funding round led by Odyssey Ventures, with participation from 33East, JSK Investments, Alumni Ventures, and returning investors. The company develops specialized semiconductors for neural devices, including brain-computer interfaces (BCIs), neuromodulation systems, and wearables. The new capital will be used to scale engineering and commercial teams, bring products to market, support customer adoption, and expand into the US market. MintNeuro has already delivered working silicon and has partnerships with Motif Neurotech and Amber Therapeutics, including a multi-year commercial chip supply agreement with Motif. The company aims to become the foundational semiconductor platform for the global neurotechnology industry.
Receive all future signals for Morningside & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.